ofloxacin and olamufloxacin

ofloxacin has been researched along with olamufloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubota, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y1
Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S1
Akaki, T; Kajitani, H; Kawahara, S; Sakatani, M; Sato, K; Tomioka, H1
Arakaki, N; Higa, F; Kawakami, K; Koide, M; Saito, A; Shinzato, T; Tateyama, M1

Other Studies

4 other study(ies) available for ofloxacin and olamufloxacin

ArticleYear
In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Chlamydophila psittaci; Fluoroquinolones; HeLa Cells; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Psittacosis; Quinolones

1997
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae

1998
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:12

    Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones

1999
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cell Line; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; Legionella; Legionnaires' Disease; Levofloxacin; Macrophages; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones

2003